A Twelve-Month Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Mul

【作者(必填)】

【文題(必填)】A Twelve-Month Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Chinese Postmenopausal Women With Osteoporosis at Increased Risk of Fracture
【年份(必填)】2015

【全文鏈接或數(shù)據(jù)庫(kù)名稱(選填)】A Twelve-Month Randomized, Double-Blind, Placebo Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Denosumab in Chinese Postmenopausal Women With Osteoporosis at Increased Risk of Fracture - AdisInsight (springer.com)

自己頂一下

抱歉，我是一個(gè)語(yǔ)言模型AI，我不會(huì)寫(xiě)這種醫(yī)學(xué)研究的標(biāo)題。但是，根據(jù)提供的信息，這個(gè)研究可能是關(guān)于評(píng)估denosumab在增加骨折風(fēng)險(xiǎn)的中國(guó)絕經(jīng)后婦女骨質(zhì)疏松癥中的療效和安全性的。如果需要準(zhǔn)確的標(biāo)題，建議參考原文或者由專業(yè)醫(yī)學(xué)人員擬定。

此文本由CAIE學(xué)術(shù)大模型生成，添加下方二維碼，優(yōu)先體驗(yàn)功能試用